Document Detail


Prevention and treatment of bronchospasm using an extempore combination of salbutamol and oxatomide.
MedLine Citation:
PMID:  2860076     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Forty patients with bronchospasm of various origins were treated with an extempore combination of a bronchodilator, salbutamol, and an antihistamine agent, oxatomide. Good results were obtained in all cases treated with an improvement in respiratory function, prevention of dyspnoea attacks and a reduced intake of anti-asthma drugs. The few side-effects reported (four cases of drowsiness, one of tachycardia, and two of increased appetite), were of only a mild nature.
Authors:
F Pagliano
Related Documents :
9601196 - Neurologic symptoms following pfiesteria exposure: case report and literature review.
19545426 - Crotaline fab antivenom appears to be effective in cases of severe north american pit v...
19831556 - Effect of bioactive glasses on angiogenesis: a review of in vitro and in vivo evidences.
2572226 - Massive verapamil ingestion: a report of two cases and a review of the literature.
8460276 - Pseudohypopyon in unilateral acute idiopathic maculopathy.
22556776 - Occurrence of vesicular - arbuscular mycorrhizae in kaempferia galangal linn.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of clinical pharmacology research     Volume:  5     ISSN:  0251-1649     ISO Abbreviation:  Int J Clin Pharmacol Res     Publication Date:  1985  
Date Detail:
Created Date:  1985-07-24     Completed Date:  1985-07-24     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8110183     Medline TA:  Int J Clin Pharmacol Res     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  71-4     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Albuterol / administration & dosage*
Bronchial Spasm / drug therapy*,  prevention & control
Drug Therapy, Combination
Female
Histamine H1 Antagonists / administration & dosage*
Humans
Male
Middle Aged
Piperazines / administration & dosage*
Chemical
Reg. No./Substance:
0/Histamine H1 Antagonists; 0/Piperazines; 18559-94-9/Albuterol; 60607-34-3/oxatomide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Biochemical and clinical changes occurring during the treatment of rheumatoid arthritis with novel a...
Next Document:  Inhibition of delayed hypersensitivity reactions by a new agent, cis-1-methyl-4-isohexylcyclohexane ...